Mydecine Innovations signs definitive agreement for acquisition of NeuroPharm Inc.
DENVER: Mydecine Innovations Group Inc. has entered into a definitive share exchange agreement for the acquisition of 100% of NeuroPharm Inc., a Canadian-based developer of natural psychedelic-based treatments for mental health disorders in the Canadian and United States veteran communities….